Navigation Links
Neuropathy Association Research Grants Advance the Understanding of Diabetic Neuropathy and Autoimmune Neuropathies

NEW YORK, Sept. 22 /PRNewswire-USNewswire/ -- The Neuropathy Association has announced two awardees for its annual Scientific Research Grants Program.

Every year, The Neuropathy Association--the leading national non-profit organization dedicated to finding cures for peripheral neuropathies--awards two scientific research grants, each for $80,000 over a two-year period.

This year's grant recipients--Dennis Paul, Ph.D. and co-principal investigator, Harry J. Gould, M.D., Ph.D. of Louisiana State University Health Sciences Center New Orleans and Glaucia C. Furtado, Ph.D. of Mount Sinai School of Medicine--were chosen from thirteen applicants involved in neuropathy research at medical institutions across North America.

Drs. Dennis Paul and Harry Gould--co-investigators on the proposal, Sodium Channels, Sodium Pumps, Inflammation, and Diabetic Neuropathy--are investigating the concomitant role of diabetes and inflammation in the development of diabetic neuropathy. They are hopeful that by studying the biological and physical manifestations of diabetic neuropathy--and specifically, the role of nerve cell death by lysis (or bursting)--they will better understand the pathogenesis of one of the most common, and debilitating, complications of diabetes.

Dr. Paul notes, "Understanding the mechanism of nerve cell survival after inflammatory or neuropathic insult will lead to new treatments and preventive strategies for diabetic neuropathy."

Dr. Glaucia Furtado's proposal, Role of CCR7 in Peripheral Neuropathy, is based on the hypothesis that the lack of CCR7--protein receptors normally found on white blood cells (or WBCs) of the immune system--induces an autoimmune demyelinating neuropathy. CCR7 receptors are responsible for guiding migration of WBCs to and within lymph tissues, where they initiate an immune response.

Dr. Furtado explains, "Besides providing new clues for how the immune system works, this study will help us identify therapeutics that block the development of autoimmune neuropathies."

Thomas H. Brannagan, III, M.D., the Association's medical advisor affirms, "We continue to invest in critical research that builds on our understanding of neuropathy's many forms, hopeful that our investments will lead to more effective treatment and cures."

About Peripheral Neuropathy

Peripheral neuropathy is one of the most common chronic diseases in the U.S., affecting more than 20 million Americans. Neuropathy results from injury to the peripheral nerves--the motor, sensory and autonomic nerves--connecting the spinal cord to the muscles, skin, blood vessels and internal organs. It usually affects the hands and feet, causing weakness, numbness, lack of coordination or pain.

Approximately 30% of neuropathies are "idiopathic," meaning of an unknown cause; 30% are caused by diabetes. Other causes include autoimmune disorders, tumors, heredity, nutritional deficiencies, infections, trauma, and toxins.

About The Neuropathy Association

The Neuropathy Association is the leading national nonprofit organization providing neuropathy patient support and education, advocating for patients' interests, and supporting critical research. The Association has more than 50,000 members and supporters and a nationwide network of 135 patient support groups, 5 chapters, and 12 Neuropathy Centers of Excellence.

For information about peripheral neuropathy and The Neuropathy Association, visit

Contact Tina Tockarshewsky at (212) 692-0380

SOURCE The Neuropathy Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Neuropathy Patients, Doctors and Medical Professionals Rally in Sacramento to Demand Access to Lifesaving Medical Treatments
2. First-Time National Poll Confirms Neuropathy Hits Millions in Their Prime
3. Unexpected Positive Finding Expands Potential for Quigley QR333 Drug for Diabetic Neuropathy; Findings Suggest Possible Disease Modification
4. Gene Therapy Improves Diabetic Neuropathy in Study
5. "Electric Socks" for Neuropathy??
6. ReBuilder Medical (RBRM) Neuropathy Market Doubles to $5 Billion
7. Doctors Issue New Neuropathy Test Guidelines
8. Quigley Announces Completion of Phase IIb Clinical Study of QR-333 For Diabetic Peripheral Neuropathy on November 25, 2008; Collection and Evaluation of Study Data to Begin Immediately Thereafter
9. The Neuropathy Associations Scientific Research Grants Focus: Autoimmune and Chemotherapy-Induced Neuropathies
10. The cause of all hereditary sensory and autonomic neuropathy type II cases has been established
11. The Neuropathy Association Featured on NBCs Today Show as Part of National Neuropathy Week
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... American Specialty ... Program have announced their endorsement of the Medical Fitness Network (MFN), a ... proud to have the MFN as one of our endorsed organizations,” said ASH ...
(Date:11/24/2015)... N.Y. (PRWEB) , ... November 24, 2015 , ... Autism ... Tuesday, the global movement driven by social media and the generosity of people around ... then encourage their social media networks to give – and share the personal stories ...
(Date:11/24/2015)... ... November 24, 2015 , ... World Patent ... Blending, a household invention that revolutionizes the vending machine industry by providing healthy ... is worth $2 billion," says Scott Cooper, CEO and Creative Director of World ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Robert Yeager ... Trend Report . Throughout the past year there have been multiple breakthroughs and challenges ... During this transition, PharmMD has enabled their customers and partners to stay ahead of ...
(Date:11/24/2015)... ... November 24, 2015 , ... Dehydration, defined as a loss of body water ... the hot sun, and heat stroke and death will quickly follow. A normal human ... Kleyne. Every cell, system and structure requires water to function properly. Kleyne, who believes ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Nov. 24, 2015   HeartWare International, Inc . ... miniaturized circulatory support technologies that are revolutionizing the treatment ... Chief Executive Officer Doug Godshall is scheduled ... Annual Healthcare Conference on December 1, 2015 at 3:00 ... in New York . ...
(Date:11/24/2015)... BERN, Switzerland , November 24, 2015 /PRNewswire/ ... Biomedical Engineering Research of the University of ... Diabetes and Clinical Nutrition of the Bern University Hospital ... exclusive collaboration to develop a novel generation artificial pancreas. ... delivery of insulin for diabetic patients with the unequalled ...
(Date:11/24/2015)... 2015 F1000Workspace - a research ... it was launched just six months ago. --> ... platform for scientists - since it was launched just six ... loaded on to F1000Workspace - a research collaboration, ... was launched just six months ago. --> ...
Breaking Medicine Technology: